Qiagen N.V. (LON:0RLT)
London
· Delayed Price · Currency is GBP · Price in EUR 41.03
-0.10 (-0.25%)
At close: Jun 27, 2025
Qiagen Employees
As of December 31, 2024, Qiagen had 5,396 total employees, including 5,067 full-time and 329 part-time employees. The number of employees decreased by 135 or -2.44% compared to the previous year.
Employees
5,396
Change (1Y)
-135
Growth (1Y)
-2.44%
Revenue / Employee
271.97K GBP
Profits / Employee
12.72K GBP
Market Cap
7.67B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| Shell | 96,000 |
| HSBC Holdings | 211,304 |
| Unilever | 115,964 |
| Rolls-Royce Holdings | 42,400 |
| British American Tobacco p.l.c. | 48,989 |
| Rio Tinto Group | 60,000 |
| RELX PLC | 36,400 |
Qiagen News
- 7 days ago - QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board - Business Wire
- 15 days ago - Qiagen and Gencurix Enter Clinical Diagnostics Partnership - Market Watch
- 15 days ago - Qiagen and Gencurix partner for oncology tests - Seeking Alpha
- 15 days ago - QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - Business Wire
- 17 days ago - Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Benzinga
- 19 days ago - QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) - Business Wire
- 4 weeks ago - Tracer Biotechnologies and QIAGEN to advance blood-based MRD testing for solid tumors - Seeking Alpha
- 4 weeks ago - Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors - Business Wire